Interpretation of medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline / 中华口腔医学杂志
Chinese Journal of Stomatology
;
(12): 128-135, 2022.
Article
Dans Chinois
| WPRIM
| ID: wpr-935838
ABSTRACT
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse event related to administration of antiresorptive or antiangiogenic medications. With the increasing usage of bone-modifying agents in cancer therapy, the incidence of MRONJ enhanced gradually, which affects the life quality of patients and interferes with cancer therapy. In 2019, Multinational Association of Supportive Care in Cancer (MASCC), International Society of Oral Oncology (ISOO) and American Society of Clinical Oncology (ASCO) convened a multidisciplinary Expert Panel to evaluate the evidence and formulate recommendations on practices in the prevention and management of MRONJ in patients with cancer. The present article made an interpretation of Medication-Related Osteonecrosis of the Jaw MASCC/ISOO/ASCO Clinical Practice Guideline so as to provide clinicians with diagnostic and therapeutic approaches for cancer patients with MRONJ.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Ostéonécrose
/
Qualité de vie
/
Agents de maintien de la densité osseuse
/
Ostéonécrose de la mâchoire associée aux biphosphonates
/
Mâchoire
/
Oncologie médicale
/
Tumeurs
Type d'étude:
Guide de pratique
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Chinese Journal of Stomatology
Année:
2022
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS